226 related articles for article (PubMed ID: 30321504)
21. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
[TBL] [Abstract][Full Text] [Related]
23. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint.
Sansam CL; Shepard JL; Lai K; Ianari A; Danielian PS; Amsterdam A; Hopkins N; Lees JA
Genes Dev; 2006 Nov; 20(22):3117-29. PubMed ID: 17085480
[TBL] [Abstract][Full Text] [Related]
24. C/EBPα regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint.
Hall JR; Bereman MS; Nepomuceno AI; Thompson EA; Muddiman DC; Smart RC
Cell Cycle; 2014; 13(22):3602-10. PubMed ID: 25483090
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of DTL enhances cell motility and promotes tumor metastasis in cervical adenocarcinoma by inducing RAC1-JNK-FOXO1 axis.
Liu S; Gu L; Wu N; Song J; Yan J; Yang S; Feng Y; Wang Z; Wang L; Zhang Y; Jin Y
Cell Death Dis; 2021 Oct; 12(10):929. PubMed ID: 34635635
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
[TBL] [Abstract][Full Text] [Related]
27. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
28. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.
Gil L; Niño SA; Chi-Ahumada E; Rodríguez-Leyva I; Guerrero C; Rebolledo AB; Arias JA; Jiménez-Capdeville ME
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155994
[TBL] [Abstract][Full Text] [Related]
29. Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.
Hu W; Wang Z; Zhang H; Mahaman YAR; Huang F; Meng D; Zhou Y; Wang S; Jiang N; Xiong J; Westermarck J; Lu Y; Wang J; Wang X; Shentu Y; Liu R
Neurotherapeutics; 2022 Mar; 19(2):570-591. PubMed ID: 35286657
[TBL] [Abstract][Full Text] [Related]
30. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease.
Banzhaf-Strathmann J; Benito E; May S; Arzberger T; Tahirovic S; Kretzschmar H; Fischer A; Edbauer D
EMBO J; 2014 Aug; 33(15):1667-80. PubMed ID: 25001178
[TBL] [Abstract][Full Text] [Related]
32. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
Zhang H; Chen W; Li Z; Huang Q; Wen J; Chang S; Pei H; Ma L; Li H
J Ethnopharmacol; 2024 Jan; 318(Pt B):116985. PubMed ID: 37532075
[TBL] [Abstract][Full Text] [Related]
33. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
[TBL] [Abstract][Full Text] [Related]
34. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?
Lopes JP; Oliveira CR; Agostinho P
Curr Alzheimer Res; 2009 Jun; 6(3):205-12. PubMed ID: 19519302
[TBL] [Abstract][Full Text] [Related]
36. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
[TBL] [Abstract][Full Text] [Related]
37. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
Lin LF; Luo HM
Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
[TBL] [Abstract][Full Text] [Related]
38. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
39. M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.
Fisher A; Pittel Z; Haring R; Bar-Ner N; Kliger-Spatz M; Natan N; Egozi I; Sonego H; Marcovitch I; Brandeis R
J Mol Neurosci; 2003; 20(3):349-56. PubMed ID: 14501019
[TBL] [Abstract][Full Text] [Related]
40. Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity.
Ippati S; Deng Y; van der Hoven J; Heu C; van Hummel A; Chua SW; Paric E; Chan G; Feiten A; Fath T; Ke YD; Haass NK; Ittner LM
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33737393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
